SIDE EFFECTS OF CHEMOTHERAPY FOR BREAST CANCER PATIENTS
Tìm thấy 10,000 tài liệu liên quan tới từ khóa "SIDE EFFECTS OF CHEMOTHERAPY FOR BREAST CANCER PATIENTS":
OVEREXPRESSION OF SYNUCLEIN-Γ PREDICTS LACK OF BENEFIT FROM RADIOTHERAPY FOR BREAST CANCER PATIENTS
Although radiotherapy following mastectomy was demonstrated to reduce the recurring risk and improve the prognosis of patients with breast cancer, it is also notorious for comprehensive side effects, hence only a selected group of patients can benefit.
BÁO CÁO HÓA HỌC:" PAR1 IS SELECTIVELY OVER EXPRESSED IN HIGH GRADE BREAST CANCER PATIENTS: A COHORT STUDY" DOCX
noma breast cancer cell line, MCF-7, which is minimallyinvasive, expresses only trace amounts of PAR1 and lowlevels of PAR2 and PAR4. These data are consistent withfindings showing that high levels of PAR1 mRNA arefound in infiltrating ductal carcinoma, whereas ver[r]
10 Đọc thêm
SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER: RETROSPECTIVE COMPARATIVE EVALUATION OF CLINICALLY AXILLARY LYMPH NODE POSITIVE AND NEGATIVE PATIENTS, INCLUDING
To evaluate the accuracy of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) in breast cancer patients with axillary lymph node (ALN) metastasis. Methods: A total of 122 patients with operable breast cancer were enrolled in this single-center retrospective study.
LIVING WELL AFTER BREAST CANCER RANDOMIZED CONTROLLED TRIAL PROTOCOL: EVALUATING A TELEPHONE-DELIVERED WEIGHT LOSS INTERVENTION VERSUS USUAL CARE IN WOMEN FOLLOWING TREATMENT FOR BREAST
Obesity, physical inactivity and poor diet quality have been associated with increased risk of breast cancer-specific and all-cause mortality as well as treatment-related side-effects in breast cancer survivors. Weight loss intervention trials in breast cancer survivors have shown that weight loss i[r]
SUMMARY OF PHD THESIS IN MEDICINE: RESEARCH OF NEO-ADJUVANT TC CHEMOTHERAPY REGIMEN RESULT AND EXPRESSION RATES OF SOME MARKERS RELATED TO TONGUE CANCER AT STAGES III AND IV (M0)
Evaluation of response rate and side effects of pre-operative and/or pre-radiotherapy neo-adjuvant TC chemotherapy regimen for treatment of tongue cancer at stages III and IV (M0). Determination of expression rates of p53, EGFR and Her2 markers and some factors related to overall survival of patient[r]
25 Đọc thêm
IMMUNOHISTOCHEMICAL SUBTYPES PREDICT THE CLINICAL OUTCOME IN HIGH-RISK NODE-NEGATIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT FEC REGIMEN: RESULTS OF A SINGLE-CENTER RETROSPECTIVE STUDY
to anthracylines may be of interest in spite of the absence of lymph node invasion.
PVI was shown to be an adverse prognostic parameter in early BC, notably in node-negative BC, where it has been considered as a surrogate for occult vascular dissem- ination [18]. Its[r]
11 Đọc thêm
UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: A retrospective
Uridine diphosphate glucuronosyltransferase 1 family polypeptide A1 (UGT1A1) is a predictive biomarker for the side-effects of irinotecan chemotherapy, which reduces the volume of tumors harboring UGT1A1 polymorphisms.
EFFECTIVENESS OF A MULTIMODAL STANDARD NURSING PROGRAM ON HEALTH-RELATED QUALITY OF LIFE IN CHINESE MAINLAND FEMALE PATIENTS WITH BREAST CANCER: PROTOCOL FOR A SINGLEBLIND CLUSTER
Breast cancer and its treatment-related adverse effects are harmful to physical, psychological, and social functioning, leading to health-related quality of life (HRQoL) impairment in patients.
POST-DIAGNOSTIC ANTIPSYCHOTIC USE AND CANCER MORTALITY: A POPULATION BASED COHORT STUDY
Many antipsychotics elevate prolactin, a hormone implicated in breast cancer aetiology however no studies have investigated antipsychotic use in patients with breast cancer. This study investigated if antipsychotic use is associated with an increased risk of cancer-specific mortality among breast ca[r]
12 Đọc thêm
EFFICACY AND SAFETY OF TARGET COMBINED CHEMOTHERAPY IN ADVANCED GASTRIC CANCER: A META-ANALYSIS AND SYSTEM REVIEW
The aim of our meta-analysis is to assess the efficacy and safety of the target combined chemotherapy for the patients with unresectable advanced or recurrent gastric cancer. The target combined chemotherapy represented a better overall survival benefit and treatment efficiency and higher incidence[r]
LUMINAL B SUBTYPE: A KEY FACTOR FOR THE WORSE PROGNOSIS OF YOUNG BREAST CANCER PATIENTS IN CHINA
13. Moon EK, Park HJ, Oh CM, Jung KW, Shin HY, Park BK, et al. Cancer incidence and survival among adolescents and young adults in Korea. PLoS One. 2014;9(5):e96088.
14. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of
14. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of
7 Đọc thêm
Optitrain: A randomised controlled exercise trial for women with breast cancer undergoing chemotherapy
Women with breast cancer undergoing chemotherapy suffer from a range of detrimental disease and treatment related side-effects. Exercise has shown to be able to counter some of these side-effects and improve physical function as well as quality of life.
Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
Immunohistochemical analysis of γ H2AX
Cells were cultured and treated on chamber slides. Seventeen hours after irradiation, cover slips were rinsed, and cells were fixed in 4% paraformaldehyde and permea- blized in methanol for 20 minutes. Cells were subse- quently washed and blocke[r]
Cells were cultured and treated on chamber slides. Seventeen hours after irradiation, cover slips were rinsed, and cells were fixed in 4% paraformaldehyde and permea- blized in methanol for 20 minutes. Cells were subse- quently washed and blocke[r]
CHAPTER 005. PRINCIPLES OF CLINICAL PHARMACOLOGY (PART 14) POTX
Chapter 005. Principles of Clinical Pharmacology (Part 14) Diagnosis and Treatment of Adverse Drug Reactions The manifestations of drug-induced diseases frequently resemble those of other diseases, and a given set of manifestations may be produced by different and[r]
6 Đọc thêm
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
Apatinib is a tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2(VEGFR-2). This study was conducted to assess the efficacy and safety of apatinib in patients with non-triple-negative metastatic breast cancer who had received prior chemotherapy for their metastatic dise[r]
CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF FOXP3+ TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH BREAST CANCER: A META-ANALYSIS
The prognostic significance of FOXP3+ tumor-infiltrating lymphocytes (TILs) in patients with breast cancer remains controversial. The aims of our meta-analysis are to evaluate its association with clinicopathological characteristics and prognostic significance in patients with breast cancer.
12 Đọc thêm
CRITICAL CARE OBSTETRICS PART 73 POTX
undertaken at approximately 16 – 20 weeks gestation. This is a time when physiological cysts have regressed and the placenta is hormonally functional and the fetus is supported independent of the corpus luteum. If an oophorectomy which removes a func-tional corpus luteum is required during th[r]
10 Đọc thêm
GERMLINE BREAST CANCER SUSCEPTIBILITY GENE MUTATIONS AND BREAST CANCER OUTCOMES
It is unclear whether germline breast cancer susceptibility gene mutations affect breast cancer related outcomes. We wanted to evaluate mutation patterns in 20 breast cancer susceptibility genes and correlate the mutations with clinical characteristics to determine the effects of these germline muta[r]
CELECOXIB INCREASES MIR-222 WHILE DETERRING AROMATASE-EXPRESSING BREAST TUMOR GROWTH IN MICE
xenograft model. After all, neither celecoxib nor aspirin were suppressors to aromatase at any levels.
Overexpression of cyclins has been observed in breast cancer [31-33]. In contrast, celecoxib and aspirin inhibit cell cycle progression through G1 phase arrest in colon ca[r]
Overexpression of cyclins has been observed in breast cancer [31-33]. In contrast, celecoxib and aspirin inhibit cell cycle progression through G1 phase arrest in colon ca[r]
13 Đọc thêm
EFFECTS OF SUPERVISED EXERCISE ON CANCER-RELATED FATIGUE IN BREAST CANCER SURVIVORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Cancer-related fatigue (CRF) is the most common and distressing symptom in breast cancer survivors. Approximately 40% to 80% of cancer patients undergoing active treatment suffer from CRF. Exercise improves overall quality of life and CRF; however, the specific effects of the training modalities are[r]